Sygnature to exhibit at Drug Discovery Chemistry conference

Sygnature Chemical Services is participating in the Drug Discovery Chemistry conference, San Diego, in April 09 to showcase it's medicinal and synthetic chemistry expertise. This years event, organised by Cambridge Healthtech Institute is taking place at the San Diego Hilton Resort. Dr Simon Hirst CEO and Dr Paul Clewlow, Senior Vice-President, Business Development will be discussing how Sygnature can accelerate clients drug discovery programmes.

About CHI's Drug Discovery Chemistry

Drug Discovery Chemistry is a highly successful event offering six conferences in one location. DDC will bring together key decision-makers from the biotechnology and pharmaceutical industries around the world. The three day programme format offers over 70 presentations, networking opportunities for more than 400 delegates, interactive panel and roundtable discussions,scientific posters and two days of exhibits.